Authors: Levi, I Modan, B Blumstein, T Luxenburg, O Yehuda-Cohen, T Shasha, B Lotan, A Bundstein, A Barzilai, A Rubinstein, E

Citation: I. Levi et al., Characteristics of clients attending confidential versus anonymous testingclinics for human immunodeficiency virus, ISR MED ASS, 3(3), 2001, pp. 184-187

Authors: Boker, LK Blumstein, T Sadetzki, S Luxenburg, O Litvak, I Akstein, E Modan, B

Citation: Lk. Boker et al., Incidence of leukemia and other cancers in Down syndrome subjects in Israel, INT J CANC, 93(5), 2001, pp. 741-744

Authors: Sadetzki, S Chetrit, A Akstein, E Keinan, L Luxenburg, O Modan, B

Citation: S. Sadetzki et al., Relinquishment of infants with Down syndrome in Israel: Trends by time, AM J MENT R, 105(6), 2000, pp. 480-485

Authors: Shani, S Siebzehner, MI Luxenburg, O Shemer, J

Citation: S. Shani et al., Setting priorities for the adoption of health technologies on a national level - the Israeli experience, HEALTH POLI, 54(3), 2000, pp. 169-185

Authors: Sadetzki, S Chetrit, A Akstein, E Luxenburg, O Keinan, L Litvak, I Modan, B

Citation: S. Sadetzki et al., Risk factors for infant mortality in Down's syndrome: a nationwide study, PAED PERIN, 13(4), 1999, pp. 442-451